Table 3 Response rate

From: Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer

 

No. of patients

CR

PR

SD

PD

Response rate (%)

Level 1

 L-OHP (100 mg m−2)

3

0

2

1

0

67 (CI: 9.4–99.2)

Level 2

 L-OHP (130 mg m−2)

28

1

13

9

5

50 (CI: 30.6–69.4)

  1. CI=confidence interval; CR=complete response; L-OHP=oxaliplatin; PD=progressive disease; PR=partial response; SD=stable disease.
Back to article page